medigraphic.com
Instituto Nacional de Salud Pública

2018, Número 3

<< Anterior Siguiente >>

salud publica mex 2018; 60 (3)


Prevalencia de síntomas de sueño y riesgo de apnea obstructiva del sueño en México

Guerrero-Zúñiga S, Gaona-Pineda EB, Cuevas-Nasu L, Torre-Bouscoulet L, Reyes-Zúñiga M, Shamah-Levy T, Pérez-Padilla R

Idioma: Español
Referencias bibliográficas: 30
Paginas: 347-355
Archivo PDF: 296.24 Kb.


RESUMEN

Objetivo. Estimar la prevalencia nacional de síntomas asociados con el sueño (SAS) en México, y su distribución por región, localidad y sexo. Material y métodos. Estudio transversal con muestreo probabilístico, representativo a nivel nacional en adultos mayores de 20 años. Se aplicó un cuestionario sobre duración de sueño, insomnio, uso de hipnóticos y riesgo de síndrome de apnea obstructiva del sueño (SAOS). Resultados. Los SAS más frecuentes fueron ronquido (48.5%) y dificultad para dormir (36.9%). Se identificó riesgo elevado de SAOS en 27.3% de los adultos, y se incrementa por índice de masa corporal (RM=1.1), edad (RM=1.03) y habitar zona urbana (RM=1.37). Se reportó insomnio en 18.8% de los participantes, que predomina en mujeres (RM=1.88). La duración promedio de sueño fue de 7.6 ± 3 horas; 28.4% de los adultos duermen ‹7 horas/ noche. Conclusiones. Existe una elevada prevalencia de SAS. Uno de cada cuatro adultos mexicanos tiene elevada probabilidad de padecer SAOS. La detección y tratamiento de SAS pudieran minimizar los efectos deletéreos en la salud.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ferrie JE, Kumari M, Salo P, Singh-Manoux A, Kivimäki M. Sleep epidemiology – a rapidly growing field. Int J Epidemiol. 2011;40(6):1431-7. https:// doi.org/10.1093/ije/dyr203

  2. Roth T, Coulouvrat C, Hajak G, Lakoma MD, Sampson NA, Shahly V, et al. Prevalence and perceived health associated with insomnia based on DSMIV- TR; International statistical classification of diseases and related health problems, tenth revision; and Reasearch diagnostic criteria/International classification of sleep disorders, second edition criteria: results from the America insomnia survey. Biol Psychiatry. 2011;69(6):592-600. https://doi. org/10.1016/j.biopsych.2010.10.023

  3. Young T, Peppard E, Gottlieb DJ. Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165(9):1217-39. https://doi. org/10.1164/rccm.2109080

  4. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230-5. https://doi.org/10.1056/NEJM199304293281704

  5. Tufik S, Santos-Silva R, Taddei JA, Azeredo-Bittencourt LR. Obstructive sleep apnea síndrome in the Sao Paulo epidemiologic sleep study. Sleep Med. 2010;11(5):441-6. https://doi.org/10.1016/j.sleep.2009.10.005

  6. Lajous M, Kurth T, Catzin-Kuhlmann A, Romieu I, Lopez-Ridaura R. Prevalence of restless legs syndrome in 69,830 Mexican women. Rev Invest Clin. 2014;66(4):303-6.

  7. Akerstedt T, Fredlund P, Gillberg M, Jansson B. A prospective study of fatal occupational accidents – relationship to sleeping difficulties and occupational factors. J Sleep Res. 2002;11(1):69-71. https://doi.org/10.1046/ j.1365-2869.2002.00287.x

  8. Wang X, Ouyang Y, Wang Z, Zhao G, Liu L, Bi Y. Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies. Int J Cardiol. 2013;169(3):207-14. https:// doi.org/10.1016/j.ijcard.2013.08.088

  9. Bouscoulet LT, Vázquez-García JC, Muiño A, Márquez M, López MV, Montes de Oca M, et al. Prevalence of sleep related symptoms in four latin american cities. J Clin Sleep Med. 2008;4(6):579-85.

  10. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Méndez Gómez- Humaran I, Gaona Pineda EB, Gómez Acosta LM, et al. Diseño metodológico de la Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Salud Publica Mex. 2017;59:299-305. https://doi.org/10.21149/8593

  11. Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American academy of sleep medicine and sleep research society. Sleep. 2015;38(6):843-4. https://doi.org/10.5665/sleep.4716

  12. American Academy of Sleep Medicine. International classification of sleep disorders. 3ra ed. Darien, IL: American Academy of Sleep Medicine, 2014.

  13. Netzer NC, Stoohs CM, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to Identify Patients at Risk for the Sleep Apnea Syndrome. Ann Intern Med. 1999;131(7):485-91. https://doi.org/10.7326/0003- 4819-131-7-199910050-00002

  14. Lohman T, Roche A, Martorell R. Anthropometric standarization reference manual. Champlaign, IL: Human Kinetics, 1988.

  15. Habicht J. Standardization of anthropometric methods in the field. PAHO Bull. 1974;76:375-84.

  16. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva: World Health Organization, 1995.

  17. Téllez A, Guerrero ME, Gutierrez F, Niño-Ramírez MP, Silva MV. Hábitos y trastornos del dormir en residentes del área metropolitana de Monterrey. Salud Mental. 1995;18(1):14-22.

  18. Beck F, Richard JB, Léger D. Insomnia and total sleep time in France: Prevalence and associated socio-demographic factors in a general population survey. Rev Neurol (París). 2013;169(12):956-64. https://doi. org/10.1016/j.neurol.2013.02.011

  19. Chaudhary NS, Grandner MA, Kackson NJ, Chakravorty S. Caffeine consumption, insomnia, and sleep duration: Results from a nationally representative sample. Nutrition. 2016;32(11-12):1193-9. https://doi. org/10.1016/j.nut.2016.04.005

  20. Fernández-Mendoza J, Vgontzas AN. Insomnia and its impact on physical and mental health. Curr Psychiatry Rep. 2013;15(12):418. https://doi. org/10.1007/s11920-013-0418-8

  21. Hale L, Phuong D. Racial differences in self-reports of sleep duration in a population-based study. Sleep. 2007;30(9):1096-103. https://doi. org/10.1093/sleep/30.9.1096

  22. McNamara JP, Wang J, Holiday DB, Paradoa M, Balkhi AM, Fernandez- Baca J, et al. Sleep disturbances associated with cigarette smoking. Psychol Health Med. 2014;19(4):410-9.

  23. Grandner MA, Hale L, Moore M, Patel N. Mortality associated with short sleep duration: The evidence, the possible mechanisms, and the future. Sleep Med Rev. 2010;14(3):191-203. https://doi.org/10.1016/j. smrv.2009.07.006

  24. Buxton OM, Marcelli E. Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med. 2010;71:1027-36. https://doi. org/10.1016/j.socscimed.2010.05.041

  25. Lou P, Zhang P, Zhang L, Chen P, Chang G, Zhang N, et al. Effects of sleep duration and sleep quality on prevalence of type 2 diabetes mellitus: A 5-year follow-up study in China. Diabetes Res Clin Pract. 2015;109(1):178-84. https://doi.org/10.1016/j.diabres.2015.04.012

  26. Colell E, Sánchez-Niubò A, Domingo-Salvany A, Delclós J, Benavides FG. Prevalencia de consumo de hipnosedantes en población ocupada y factores de riesgo. Gac Sanit. 2014;28(5):369-75. https://doi.org/10.1016/j. gaceta.2014.04.009

  27. Jaussent I, Ancelin ML, Berr C, Pérès K, Scali J, Besset A, et al. Hypnotics and mortality in an elderly general population: a 12-year prospective study. BMC Med. 2013;26(11):212. https://doi.org/10.1186/1741-7015-11-212

  28. Heinzer R, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310-8. https://doi.org/10.1016/S2213-2600(15)00043-0

  29. Hrubos-Strøm H, Randby A, Namtvedt S, Kristiansen HA, Einvik G, Benth J, et al. A Norwegian population-based study on the risk and prevalence of obstructive sleep apnea. J Sleep Res. 2011;20(1):162-70. https:// doi.org/10.1111/j.1365-2869.2010.00861.x

  30. De la Llata-Romero M, Castorena-Maldonado A, Corsi-Cabrera M, Díaz M, Haro-Valencia-R, Jimenez-Genchi A, et al. Medicina del dormir: Desarrollo, contribuciones y perspectivas. Reporte del grupo de trabajo en medicina del dormir. Rev Invest Clin. 2011;63(1):90-9.




2020     |     www.medigraphic.com